Free Trial
Notice: This company recently went public with an IPO on Tuesday, February 11th 2025. They issued 2,500,000 shares at $8.50 per share. We will continue to update data for ODYS as it becomes available.

Odysight.Ai (ODYS) Competitors

$6.56 0.00 (0.00%)
As of 02/21/2025 04:00 PM Eastern

ODYS vs. HTGMQ, OLITW, PRENW, QSIAW, SMAPW, THMO, TT, KEYS, FTV, and VLTO

Should you be buying Odysight.Ai stock or one of its competitors? The main competitors of Odysight.Ai include HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), ThermoGenesis (THMO), Trane Technologies (TT), Keysight Technologies (KEYS), Fortive (FTV), and Veralto (VLTO). These companies are all part of the "measuring and control equipment" industry.

Odysight.Ai vs.

HTG Molecular Diagnostics (NASDAQ:HTGMQ) and Odysight.Ai (NASDAQ:ODYS) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, community ranking, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.

HTG Molecular Diagnostics has a net margin of 0.00% compared to Odysight.Ai's net margin of -207.38%. HTG Molecular Diagnostics' return on equity of 0.00% beat Odysight.Ai's return on equity.

Company Net Margins Return on Equity Return on Assets
HTG Molecular DiagnosticsN/A N/A N/A
Odysight.Ai -207.38%-56.78%-43.36%

HTG Molecular Diagnostics and Odysight.Ai both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
HTG Molecular DiagnosticsN/AN/A
Odysight.AiN/AN/A

19.7% of Odysight.Ai shares are held by institutional investors. 2.6% of HTG Molecular Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Odysight.Ai has lower revenue, but higher earnings than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HTG Molecular Diagnostics$6.37M0.00-$21.59MN/AN/A
Odysight.Ai$3.03M32.78-$9.44M-$0.86-7.63

In the previous week, Odysight.Ai had 1 more articles in the media than HTG Molecular Diagnostics. MarketBeat recorded 1 mentions for Odysight.Ai and 0 mentions for HTG Molecular Diagnostics. HTG Molecular Diagnostics' average media sentiment score of 0.00 beat Odysight.Ai's score of -1.00 indicating that HTG Molecular Diagnostics is being referred to more favorably in the media.

Company Overall Sentiment
HTG Molecular Diagnostics Neutral
Odysight.Ai Negative

HTG Molecular Diagnostics has a beta of 2.57, suggesting that its stock price is 157% more volatile than the S&P 500. Comparatively, Odysight.Ai has a beta of 0.48, suggesting that its stock price is 52% less volatile than the S&P 500.

Summary

HTG Molecular Diagnostics beats Odysight.Ai on 7 of the 10 factors compared between the two stocks.

Get Odysight.Ai News Delivered to You Automatically

Sign up to receive the latest news and ratings for ODYS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ODYS vs. The Competition

MetricOdysight.AiOptical instruments & lenses IndustryBusiness SectorNASDAQ Exchange
Market Cap$99.32M$14.05B$7.81B$8.98B
Dividend YieldN/A1.24%2.20%3.85%
P/E Ratio-7.6334.8533.8518.82
Price / Sales32.788.6467.5780.73
Price / CashN/A20.4832.3137.47
Price / Book3.846.775.424.64
Net Income-$9.44M$324.03M$187.27M$245.69M
7 Day PerformanceN/A-4.03%-2.92%-2.63%
1 Month PerformanceN/A-10.92%-2.68%-2.37%
1 Year PerformanceN/A4.96%18.85%13.65%

Odysight.Ai Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ODYS
Odysight.Ai
N/A$6.56
flat
N/AN/A$99.33M$3.03M0.0040Negative News
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/AN/A$0.00$6.37M0.0090High Trading Volume
OLITW
OmniLit Acquisition
N/A$0.09
+10.4%
N/A-18.3%$0.00N/A0.003Gap Up
PRENW
Prenetics Global
N/A$0.01
-5.1%
N/A+66.7%$0.00$25.56M0.001Negative News
Gap Down
High Trading Volume
QSIAW
Quantum-Si
N/A$0.61
+3.4%
N/A+220.3%$0.00$2.27M0.00150Negative News
SMAPW
SportsMap Tech Acquisition
N/A$0.07
-1.5%
N/AN/A$0.00N/A0.00N/AGap Up
THMO
ThermoGenesis
N/AN/AN/AN/A$0.00$9.44M0.0040News Coverage
TT
Trane Technologies
4.415 of 5 stars
$370.04
+2.0%
$415.25
+12.2%
+28.3%$83.00B$19.84B32.8945,000Positive News
KEYS
Keysight Technologies
3.9597 of 5 stars
$185.18
+0.3%
$180.80
-2.4%
+21.7%$31.93B$4.98B52.9115,500Upcoming Earnings
Analyst Upgrade
Positive News
FTV
Fortive
4.4858 of 5 stars
$83.05
+1.6%
$87.64
+5.5%
-5.2%$28.37B$6.23B35.1918,000Positive News
VLTO
Veralto
3.2958 of 5 stars
$97.72
-0.2%
$112.55
+15.2%
+15.1%$24.21B$5.19B29.2616,000Positive News

Related Companies and Tools


This page (NASDAQ:ODYS) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners